Trial Profile
The Pharmacokinetics of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children: a Pilot Study of Lopimune vs. the Branded Product (SURF Study)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Acronyms SURF
- 07 Jan 2010 Results published in the Journal of Antimicrobial Chemotherapy.
- 24 Feb 2009 Actual end date changed from Dec 2008 to Feb 2009 as reported by ClinicalTrials.gov.
- 24 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.